Published in J Clin Invest on April 01, 1968
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest (1972) 3.96
Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci U S A (1978) 3.10
Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A (1990) 2.87
A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest (1974) 2.78
Chemical classes of amyloid substance. Am J Pathol (1971) 2.43
Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest (1984) 2.41
Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med (1978) 2.09
Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci U S A (2002) 2.01
Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med (1976) 1.91
Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol (1992) 1.86
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A (1995) 1.83
Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci U S A (1986) 1.78
Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci U S A (1984) 1.74
Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations. J Exp Med (1969) 1.66
Isolation of a non-collagenous reticulin component and its primary characterization. Br J Exp Pathol (1973) 1.64
Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. Proc Natl Acad Sci U S A (1999) 1.63
Mouse amyloid protein AA: Homology with nonimmunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci U S A (1976) 1.60
Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci U S A (1998) 1.58
Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci U S A (1987) 1.56
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest (1993) 1.51
Antibody-mediated resolution of light chain-associated amyloid deposits. Am J Pathol (2000) 1.49
Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci U S A (1983) 1.42
Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J Clin Invest (1981) 1.41
A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin. J Exp Med (1981) 1.39
Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med (1974) 1.39
Raft lipids as common components of human extracellular amyloid fibrils. Proc Natl Acad Sci U S A (2005) 1.38
Binding specificity of serum amyloid P component for the pyruvate acetal of galactose. J Exp Med (1984) 1.38
Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest (1982) 1.37
Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Protein Sci (1995) 1.35
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci U S A (1992) 1.35
Amyloid deposits in articular cartilage. Ann Rheum Dis (1970) 1.30
Senile cardiac amyloid: evidence that fibrils contain a protein immunologically related to prealbumin. Immunology (1981) 1.30
Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest (1989) 1.29
New, third class of amyloid fibril protein. J Exp Med (1974) 1.25
Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest (1986) 1.23
Senile amyloidosis: a protean manifestation of the aging process. J Clin Pathol (1980) 1.22
Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin Exp Immunol (1991) 1.22
The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J (1981) 1.22
Transgenic mouse model of AA amyloidosis. Am J Pathol (1999) 1.21
Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 1.20
Micro-imaging of amyloid in mice. Methods Enzymol (2006) 1.19
Intracellular localization of human amyloid by fluorescence and electron microscopy. Am J Pathol (1970) 1.16
Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol (1990) 1.16
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J Clin Invest (1996) 1.09
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08
Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol (1999) 1.05
Pulmonary vascular amyloidosis in aged dogs. A new form of spontaneously occurring amyloidosis derived from apolipoprotein AI. Am J Pathol (1992) 1.04
Light chain-associated amyloid deposits comprised of a novel kappa constant domain. Proc Natl Acad Sci U S A (1998) 1.00
Immunologic studies of water-soluble human amyloid fibrils. Comparative studies of eight amyloid preparations. J Exp Med (1969) 0.99
AA protein-related renal amyloidosis in drug addicts. Am J Pathol (1983) 0.98
Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains. Biochemistry (2007) 0.98
Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis. Am J Pathol (2006) 0.98
Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. Am J Pathol (2007) 0.98
Induction in mice of human light-chain-associated amyloidosis. Am J Pathol (1992) 0.97
Congo red dichroism with dispersed amyloid fibrils, an extrinsic cotton effect. Proc Natl Acad Sci U S A (1970) 0.97
Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. J Nucl Med (2006) 0.97
Amyloid of the seminal vesicles. A distinctive and common localized form of senile amyloidosis. Am J Pathol (1983) 0.96
Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III. Biochem J (1986) 0.96
Immunogenicity of amyloid. Immunology (1971) 0.96
Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils. Biochem J (1991) 0.95
The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein. Biochem J (1985) 0.94
Demonstration of AA-protein in formalin-fixed, paraffin-embedded tissues. Am J Pathol (1982) 0.93
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis. Molecules (2015) 0.92
Immunoglobulin heavy-chain-associated amyloidosis. Proc Natl Acad Sci U S A (1990) 0.92
Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II. Am J Pathol (1986) 0.92
Individual antigenic specificity and cross-reactions among amyloid preparations from different individuals. Clin Exp Immunol (1972) 0.90
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. Protein Sci (2001) 0.89
Primary amyloidosis A. Immunohistochemical and biochemical characterization. Am J Pathol (1987) 0.89
Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts. Biochem Biophys Res Commun (2013) 0.88
Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid. J Biol Chem (2011) 0.88
A serum AA-like protein as a common constituent of secondary amyloid fibrils. Clin Exp Immunol (1982) 0.88
Some effects of the administration of endotoxin in mice. Specific cleavage of serum albumin by an acid protease and the generation of amyloid serum component. J Clin Invest (1979) 0.87
Presence of glycosaminoglycans in purified AA type amyloid fibrils associated with juvenile rheumatoid arthritis. Ann Rheum Dis (1989) 0.86
The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL). Biochem J (1988) 0.85
Characterization of serum amyloid A protein mRNA expression and secondary amyloidosis in the domestic duck. Proc Natl Acad Sci U S A (1996) 0.85
Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy. Am J Pathol (1984) 0.85
Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy. Ann Rheum Dis (1979) 0.85
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis. Protein Sci (2007) 0.85
Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chains. J Biol Chem (2009) 0.84
Stimulation of glycosaminoglycan biosynthesis by amyloid fibrils. Biochem J (1975) 0.83
Immunological characterization of amyloid fibrils in tissue sections. Clin Exp Immunol (1972) 0.83
Polymorphism of Amyloid Fibrils In Vivo. Angew Chem Int Ed Engl (2016) 0.82
Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissues. Clin Exp Immunol (1983) 0.82
Amyloid-related serum component (protein ASC) IN LEPROSY PATIENTS. Infect Immun (1975) 0.82
Micropurification techniques in the analysis of amyloid proteins. J Clin Pathol (2003) 0.81
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol (2000) 0.81
Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloid. Biochem J (1992) 0.81
Protein folding pathology in domestic animals. J Zhejiang Univ Sci (2004) 0.81
Synchrotron x-ray microdiffraction reveals intrinsic structural features of amyloid deposits in situ. Biophys J (2011) 0.81
Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice. Amyloid (2014) 0.79
'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils. Clin Exp Immunol (1984) 0.79
Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis. Br J Exp Pathol (1985) 0.79
Extracellular deposition of mouse senile AApoAII amyloid fibrils induced different unfolded protein responses in the liver, kidney, and heart. Lab Invest (2014) 0.79
Pathological study on amyloidosis in Cygnus olor (mute swan) and other waterfowl. Med Mol Morphol (2008) 0.79
High molecular weight glycosaminoglycans in AA type amyloid fibril extracts from human liver. Ann Rheum Dis (1991) 0.78
Amyloid fibril protein AA in Papua New Guinean amyloidosis. Clin Exp Immunol (1976) 0.78
Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding - In vitro characterization. Biochem Biophys Rep (2016) 0.78
Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice. Clin Exp Immunol (2015) 0.77
Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils? Clin Exp Immunol (1986) 0.77
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys (1961) 19.31
A modified procedure for lead staining of thin sections. J Biophys Biochem Cytol (1961) 17.60
Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature (1959) 4.43
The structural basis of proteinuria in man; electron microscopic studies of renal biopsy specimens from patients with lipid nephrosis, amyloidosis, and subacute and chronic glomerulonephritis. Am J Pathol (1959) 2.87
High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol (1967) 2.16
The ultrastructure of human amyloid as revealed by the negative staining technique. J Ultrastruct Res (1966) 2.13
THE SITE OF FORMATION AND ULTRASTRUCTURE OF AMYLOID. Am J Pathol (1963) 2.11
[The fine structure of the spleen and liver in experimental amyloidosis]. Z Zellforsch Mikrosk Anat (1960) 2.06
Amyloid. Extraction and preliminary characterization of some proteins. Arch Pathol (1962) 1.81
Amyloid. 3. A protein related to the subunit structure of human amyloid fibrils. Proc Natl Acad Sci U S A (1966) 1.73
Experimental amyloidosis. I. Light and electron microscopic observation of spleen and lymph nodes. Lab Invest (1962) 1.72
A study of the fine structure of the amyloid associated with familial Mediterranean fever. Am J Pathol (1962) 1.41
[Comparative studies on amino acids in blood proteins, liver protein, amyloid, hyalin and collagen]. Virchows Arch (1955) 1.40
Solubility characteristics of isolated amyloid fibrils. Biochim Biophys Acta (1965) 1.20
[Quantitative amino acid analysis of amyloid substance, electrophoretic serum protein fractions and connective tissue proteins]. Arztl Forsch (1953) 1.17
Isolation of highly purified amyloid. Isr J Med Sci (1968) 1.07
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum (1997) 6.04
Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med (1967) 5.88
Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med (1966) 5.26
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell (1995) 4.32
The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest (1972) 3.96
Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations. J Virol (1984) 3.54
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
The interaction of mycoplasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils. J Exp Med (1966) 3.38
Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J Exp Med (1973) 3.22
Studies on human platelet granules and membranes. J Clin Invest (1966) 3.22
Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest (1975) 3.17
Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med (1966) 3.15
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A (1996) 3.07
Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med (1980) 2.87
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
The percentage of monocytes among "mononuclear" cell fractions obtained from normal human blood. J Immunol (1974) 2.69
IRS-2 pathways integrate female reproduction and energy homeostasis. Nature (2000) 2.45
Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis. Cell (1985) 2.38
Tumor necrosis factor in familial Mediterranean fever. Am J Med (1991) 2.37
A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med (1974) 2.29
Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med (1986) 2.29
Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (1985) 2.28
HTLV tax and mycosis fungoides. N Engl J Med (1993) 2.23
The development of subretinal microphotodiodes for replacement of degenerated photoreceptors. Ophthalmic Res (1997) 2.20
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet (1999) 2.19
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr (1999) 2.10
Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol (1992) 2.09
Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med (1978) 2.09
Isolation and partial characterization of SAA-an amyloid-related protein from human serum. J Immunol (1976) 2.05
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol (1990) 2.05
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1987) 2.03
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS) Clin Exp Rheumatol (1997) 2.01
Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet (1998) 1.95
The phagosomes in rheumatoid synovial fluid leukocytes: a light, fluorescence, and electron microscope study. Arthritis Rheum (1966) 1.93
The ultrastructure of lymphocytes. Semin Hematol (1969) 1.93
Magnetic brain stimulation with a double coil: the importance of coil orientation. Electroencephalogr Clin Neurophysiol (1992) 1.91
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med (1992) 1.90
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved. J Virol (1979) 1.87
Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies. J Immunol (1983) 1.87
Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med (1977) 1.86
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit. J Biol Chem (1977) 1.83
MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid (1999) 1.81
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Current concepts of amyloid. Adv Immunol (1972) 1.75
Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum (1975) 1.73
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
Human monoclonal gamma G-cryoglobulins with anti-gamma-globulin activity. J Clin Invest (1968) 1.72
The actin and myosin filaments of human and bovine blood platelets. J Clin Invest (1972) 1.71
The submembranous fibrils of human blood platelets. J Cell Biol (1970) 1.70
Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations. J Exp Med (1969) 1.66
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet (1999) 1.65
A comparison of proteinpolysaccharides of bovine nasal cartilage isolated and fractionated by different methods. J Biol Chem (1970) 1.65
Isolation of a non-collagenous reticulin component and its primary characterization. Br J Exp Pathol (1973) 1.64
Structural studies of human gamma-G-myeloma proteins of different antigenic subgroups and genetic specificities. J Exp Med (1966) 1.62
The separation of new forms of the proteinpolysaccharides of bovine nasal cartilage. J Biol Chem (1966) 1.61
Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg Oral Med Oral Pathol (1994) 1.58
Interaction of immunoglobulins with liposomes. J Clin Invest (1974) 1.58
The interaction of mycoplasmas with mammalian cells. II. Monocytes and lymphocytes. J Exp Med (1966) 1.57
In vivo transcription of the 5'-terminal extracistronic region of vesicular stomatitis virus RNA. J Virol (1981) 1.56
Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol (1980) 1.55
The acid-soluble fraction of amyloid--a fibril forming protein. Biochim Biophys Acta (1972) 1.52
NhaA of Escherichia coli, as a model of a pH-regulated Na+/H+antiporter. Biochim Biophys Acta (2004) 1.51
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
Visual influence on human locomotion. Modulation to changes in optic flow. Exp Brain Res (1997) 1.47
Electron microscopic studies of human granulocytes: structural variations related to function. Semin Hematol (1968) 1.47
F waves and motor unit size. Muscle Nerve (1992) 1.46
Elastase-type proteases on the surface of human blood monocytes: possible role in amyloid formation. J Immunol (1980) 1.45
White cell reduction by filtration may significantly decrease human T-lymphotropic virus type 1 Tax sequences and Tax-encoded proteins in blood used for transfusion. Transfusion (1998) 1.44
Microfibrils of blood platelets: their relationship TO MICROTUBULES AND THE CONTRACTILE PROTEIN. J Clin Invest (1969) 1.43
Proteinpolysaccharides from human articular and costal cartilage. J Clin Invest (1965) 1.43
Histidine-226 is part of the pH sensor of NhaA, a Na+/H+ antiporter in Escherichia coli. Proc Natl Acad Sci U S A (1993) 1.42
Protracted arthritis in familial Mediterranean fever. Rheumatol Rehabil (1977) 1.42
Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci U S A (1983) 1.42
Letter: Colchicine in familial Mediterranean fever. N Engl J Med (1976) 1.42
Studies on antigen-binding activity of macroglobulin antibody subunits and their enzymatic fragments. J Biol Chem (1969) 1.41
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs. J Virol (1984) 1.40
A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin. J Exp Med (1981) 1.39
Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A (1995) 1.39
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A (2000) 1.39
Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol (1994) 1.39
Lymphocyte plasma membranes: analysis of proteins and glycoproteins by SDS-gel electrophoresis. Blood (1973) 1.38
Structure of connective tissues, a chemical point of view. Fed Proc (1966) 1.38